CBI books Surya Pharmaceuticals in â¹621cr bank fraud case
The CBI has registered a case against Delhi-based Surya Pharmaceuticals for allegedly cheating a consortium of five banks of â¹621 crore. Punjab and Sind Bank filed a complaint against Surya Pharmaceuticals and a Dubai-based company, alleging they had defrauded the banks and diverted funds through group companies. The CBI conducted searches at seven locations in connection with the case.